Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
May 31 2024 - 4:47PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
SCHEDULE
14A INFORMATION
Proxy
Statement Pursuant to Section 14(a) of the
Securities
Exchange Act of 1934
(Amendment
No. )
Filed
by the Registrant ☒
Filed
by a Party other than the Registrant ☐
Check
the appropriate box:
☐ |
Preliminary
Proxy Statement |
☐ |
Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
☐ |
Definitive
Proxy Statement |
☐ |
Definitive
Additional Materials |
☒ |
Soliciting
Material Pursuant to §240.14a-12 |
![](https://www.sec.gov/Archives/edgar/data/937556/000121390024048515/image_001.jpg)
MASIMO
CORPORATION
(Name
of Registrant as Specified In Its Charter)
(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment
of Filing Fee (Check the appropriate box): |
|
☒ |
No
fee required. |
☐ |
Fee
paid previously with preliminary materials. |
☐ |
Fee
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
Persons
who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently
valid OMB control number.
On
May 31, 2024, in response to certain statements recently made by Politan Capital Management LP (“Politan”) regarding
settlement negotiations and Chris Chavez’s nomination for election to the board of directors of Masimo Corporation
(“Masimo” or the “Company”), Masimo issued the following clarifying statement to the media:
#
# #
“Each
‘compromise’ that Mr. Koffey offered involved Politan controlling a majority of the Masimo Board, without earning the support
of a majority of Masimo’s stockholders and without paying any control premium. The process for identifying Mr. Chavez was abbreviated
due to Rolf Classon’s sudden resignation three weeks ago. Mr. Kiani’s prior acquaintance with Mr. Chavez was in connection
with their service on the Medical Device Manufacturers Association board, from which Mr. Chavez resigned more than 12 years ago.”
#
# #
Forward-Looking
Statements
This
communication includes forward-looking statements as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E
of the Securities Exchange Act of 1934, as amended, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking
statements include, among others, statements regarding the 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”)
of Masimo and the potential stockholder approval of the Board’s nominees. These forward-looking statements are based on current
expectations about future events affecting Masimo and are subject to risks and uncertainties, all of which are difficult to predict and
many of which are beyond Masimo’s control and could cause its actual results to differ materially and adversely from those expressed
in its forward-looking statements as a result of various risk factors, including, but not limited to (i) uncertainties regarding a potential
separation of Masimo’s Consumer Business, (ii) uncertainties regarding future actions that may be taken by Politan in furtherance
of its nomination of director candidates for election at the 2024 Annual Meeting, (iii) the potential cost and management distraction
attendant to Politan’s nomination of director nominees at the 2024 Annual Meeting and (iv) factors discussed in the “Risk
Factors” section of Masimo’s most recent reports filed with the Securities and Exchange Commission (“SEC”), which
may be obtained for free at the SEC’s website at www.sec.gov. Although Masimo believes that the expectations reflected in its forward-looking
statements are reasonable, the Company does not know whether its expectations will prove correct. All forward-looking statements included
in this communication are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place
undue reliance on these forward-looking statements, which speak only as of today’s date. Masimo does not undertake any obligation
to update, amend or clarify these statements or the “Risk Factors” contained in the Company’s most recent reports filed
with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities
laws.
Additional
Information Regarding the 2024 Annual Meeting of Stockholders and Where to Find It
The
Company has filed a preliminary proxy statement and draft form of GOLD proxy card with the U.S. Securities and Exchange Commission (the
“SEC”) in connection with its solicitation of proxies for its 2024 Annual Meeting. The proxy statement is in preliminary
form and the Company intends to file and mail a definitive proxy statement to its stockholders. THE COMPANY’S STOCKHOLDERS ARE
STRONGLY ENCOURAGED TO READ THE DEFINITIVE PROXY STATEMENT (AND ANY AMENDMENTS AND SUPPLEMENTS THERETO) AND ACCOMPANYING GOLD PROXY CARD
WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION. Stockholders may obtain the proxy statement, any amendments or
supplements to the proxy statement and other documents as and when filed by the Company with the SEC without charge from the SEC’s
website at www.sec.gov.
Certain
Information Regarding Participants
The
Company, its directors and certain of its executive officers and employees may be deemed to be participants in connection with the solicitation
of proxies from the Company’s stockholders in connection with the matters to be considered at the 2024 Annual Meeting. Information
regarding the direct and indirect interests, by security holdings or otherwise, of the Company’s directors and executive officers
in the Company is included in Amendment No. 1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 30,
2023 under the heading “Security Ownership of Certain Beneficial Owners and Management”, filed with the SEC on April 29,
2024, which can be found through the SEC’s website at https://www.sec.gov/ix?doc=/Archives/edgar/data/937556/000093755624000027/masi-20231230.htm
and in the Company’s preliminary proxy statement for the 2024 Annual Meeting, which was filed with the SEC on May 31, 2024 and
can be found through the SEC’s website at https://www.sec.gov/ix?doc=/Archives/edgar/data/937556/000121390024048182/ea0206756-01.htm,
and will be included in the Company’s definitive proxy statement for the 2024 Annual Meeting, once available. Changes to the direct
or indirect interests of Masimo’s securities by directors and executive officers are set forth in SEC filings on Statements of
Change in Ownership on Form 4 filed with the SEC on April 30, 2024 and May 3, 2024, which can be found through the SEC’s website
at https://www.sec.gov/Archives/edgar/data/937556/000093755624000030/xslF345X05/wk-form4_1714522261.xml and https://www.sec.gov/Archives/edgar/data/937556/000093755624000032/xslF345X05/wk-form4_1714772837.xml,
respectively. More detailed and updated information regarding the identity of these potential participants, and their direct or indirect
interests of the Company, by security holdings or otherwise, will be set forth in the proxy statement for the 2024 Annual Meeting and
other materials to be filed with the SEC. These documents, when filed, can be obtained free of charge from the sources indicated above.
2
Masimo (NASDAQ:MASI)
Historical Stock Chart
From May 2024 to Jun 2024
Masimo (NASDAQ:MASI)
Historical Stock Chart
From Jun 2023 to Jun 2024